Home›Companies›Healthcare›Valius Sciences

Valius Health, Inc.

Cancer diagnostics help patients find potential treatment options.

Updated Nov 10, 2026·Latest SEC filing Apr 13, 2026·Suggest an edit

About Valius Sciences

Valius Sciences is a private company based in San Francisco, California, incorporated in 2025 in Delaware. It has reported $9,650,002 raised in one offering on Form D since April 2026. Its chief executive is Edward Larkin.

Funding Rounds (SEC Form D)

First saleFiled with SECAmount soldInvestorsAvg. checkTermsFiling
Mar 25, 2026Apr 13, 2026$9,650,002of $10.1M target6$1.6MEquityRule 506(b)Form D ↗

First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.

Leadership Team

Executive officers and directors listed on Valius Sciences's Form D filed Apr 13, 2026.

Edward Larkin
Edward Larkin
Chief Executive Officer and director

Sources

  1. SECValius Health, Inc. filing history
  2. CompanyValius Sciences team